RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Gallbladder Neoplasms
Accession: DOID:9000011
browse the term
Definition: Tumors or cancer of the gallbladder.
Synonyms: exact_synonym: gallbladder neoplasm; tumor of the gallbladder
primary_id: MESH:D005706
xref: EFO:0004606
G
Apc
APC regulator of WNT signaling pathway
ISO
DNA:hypermethylation:promoter
RGD
PMID:15447999
RGD:2317199
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16904648
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cckar
cholecystokinin A receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25025063
NCBI chr14:57,292,397...57,300,747
Ensembl chr14:57,292,397...57,300,747
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24997986
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24997986
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
G
Erbb3
erb-b2 receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24997986 PMID:24997986
RGD:126781772
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:996,225...1,015,525
G
Erbb4
erb-b2 receptor tyrosine kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24997986
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
ISO
DNA:SNP: :p.D312N (rs1799793) (human)
RGD
PMID:21283657
RGD:5688734
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
G
Faslg
Fas ligand
disease_progression
ISO
protein:increased expression:gallbladder
RGD
PMID:15968727
RGD:2317739
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fgf2
fibroblast growth factor 2
ISO
protein:increased expression:bile
RGD
PMID:11478488
RGD:2317765
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fscn1
fascin actin-bundling protein 1
severity
ISO
RGD
PMID:19259612
RGD:2317784
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:SNP:cds:p.I105V (rs1695) (human)
RGD
PMID:16760134
RGD:2317808
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Hgf
hepatocyte growth factor
ISO
RGD
PMID:15118756
RGD:2317899
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Il1b
interleukin 1 beta
susceptibility
ISO
associated with Cholelithiasis;DNA:polymorphism:promoter:-511C>T (human)
RGD
PMID:18940468
RGD:2317216
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il4r
interleukin 4 receptor
ISO
mRNA:increased expression:gallbladder
RGD
PMID:18798553
RGD:2317263
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Keap1
Kelch-like ECH-associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18692501
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24997986
NCBI chr 4:179,916,255...179,949,613
G
Met
MET proto-oncogene, receptor tyrosine kinase
severity
ISO
protein:increased expression:gallbladder (human)
RGD
PMID:19956499
RGD:2317582
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876
G
Mgmt
O-6-methylguanine-DNA methyltransferase
disease_progression resistance
ISO
protein:decreased expression:tumor (human) DNA:transition:exon:EX5-25C>T rs12917 (human)
RGD
PMID:18158568 PMID:18708406
RGD:2317637 , RGD:2317636
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Mmp2
matrix metallopeptidase 2
disease_progression
ISO
protein:increased expression:gallbladder
RGD
PMID:18665467
RGD:2325743
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Muc1
mucin 1, cell surface associated
severity
ISO
mRNA,protein:increased expression:gallbladder
RGD
PMID:10398137
RGD:2324857
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Muc16
mucin 16, cell surface associated
ISO
protein:increased expression:serum
RGD
PMID:17542293
RGD:2325132
NCBI chr 8:16,164,531...16,323,126
G
Muc2
mucin 2, oligomeric mucus/gel-forming
ISO
protein:increased expression:gallbladder
RGD
PMID:15260848
RGD:2324651
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
Muc4
mucin 4, cell surface associated
ISO
mRNA,protein:increased expression:gallbladder
RGD
PMID:18397823
RGD:2324921
NCBI chr11:68,008,245...68,053,242
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
ISO
protein:decreased expression:gallbladder
RGD
PMID:15260848
RGD:2324651
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Muc6
mucin 6, oligomeric mucus/gel-forming
ISO
protein:decreased expression:gallbladder
RGD
PMID:15260848
RGD:2324651
NCBI chr 1:196,726,678...196,764,842
Ensembl chr 1:196,726,807...196,764,842
G
Nat2
N-acetyltransferase 2
susceptibility
ISO
DNA:SNP: :rs1495741(human)
RGD
PMID:20972438
RGD:11056814
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Ncam1
neural cell adhesion molecule 1
disease_progression
ISO
protein:increased expression:epithelial cell
RGD
PMID:15100237
RGD:2326070
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Nos2
nitric oxide synthase 2
ISO
protein:increased expression:gallbladder associated with Gallbladder Diseases; protein:decreased expression:gllbladder
RGD
PMID:14991947 PMID:14704000
RGD:2325250 , RGD:2325251
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nr1h2
nuclear receptor subfamily 1, group H, member 2
ISO
DNA:deletion:exon:exons 5 and 6, estrogen dependent
RGD
PMID:20679224
RGD:6482195
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
G
Ogg1
8-oxoguanine DNA glycosylase
susceptibility
ISO
DNA:polymorphism: :p.S326C (human) DNA:SNPs: :rs2072668, p.S326C (rs1052133)(human)
RGD
PMID:19266243 PMID:20564624
RGD:2317128 , RGD:8657150
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Ptgs2
prostaglandin-endoperoxide synthase 2
susceptibility
ISO
DNA:polymorphisms: :-765G>C (rs20417), -1195G>A (rs689466) (human)
RGD
PMID:19606394 PMID:17575102 PMID:19455278
RGD:2317181 , RGD:2317188 , RGD:2317182
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Runx3
RUNX family transcription factor 3
ISO
DNA:hypermethylation:promoter
RGD
PMID:15471559
RGD:2324957
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
G
Tgfb1
transforming growth factor, beta 1
susceptibility
ISO
DNA:polymorphism: : -509C>T (human)
RGD
PMID:18571008
RGD:2317641
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Thbs1
thrombospondin 1
disease_progression
ISO
RGD
PMID:10427124
RGD:2325029
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509 PMID:24997986
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Uchl1
ubiquitin C-terminal hydrolase L1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16965602
NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,485,031...41,495,590
G
Ddr2
discoidin domain receptor tyrosine kinase 2
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Ifitm1
interferon induced transmembrane protein 1
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
G
Ace
angiotensin I converting enzyme
ISO
DNA:polymorphism: :rs4646994 (human)
RGD
PMID:20438364
RGD:2325207
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Cdk1
cyclin-dependent kinase 1
ISO
protein:increased expression:gallbladder
RGD
PMID:15017593
RGD:2722465
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
G
Ddr2
discoidin domain receptor tyrosine kinase 2
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Ifitm1
interferon induced transmembrane protein 1
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
G
Apc
APC regulator of WNT signaling pathway
disease_progression
ISO
DNA:SNP::rs11954856(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
G
Apob
apolipoprotein B
susceptibility
ISO
DNA:SNP: :rs693 (human)
RGD
PMID:20082485 PMID:17696941
RGD:2325761 , RGD:2325764
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Apoe
apolipoprotein E
susceptibility
ISO
DNA:SNP:intron:rs440446 (human)
RGD
PMID:18296645
RGD:2317550
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Axin2
axin 2
disease_progression
ISO
DNA:SNP::s4791171(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:68,384,649...68,510,463
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
ISO
mRNA:increased expression:gallbladder
RGD
PMID:18497548
RGD:2324871
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
G
Calr
calreticulin
exacerbates
ISO
mRNA, protein:increased expression:gall bladder (human)
RGD
PMID:33591948
RGD:150521682
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Ccr5
C-C motif chemokine receptor 5
onset
ISO
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human)
RGD
PMID:18405329
RGD:2317570
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Ctnnb1
catenin beta 1
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:10435629 PMID:26822237
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
susceptibility
ISO
DNA:transition:5' utr:-34T>C rs743572 (human)
RGD
PMID:16381022
RGD:2317619
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
DNA:transition: :6235T>C (human) DNA:polymorphism: :p.I462V (human)
RGD
PMID:18287863 PMID:18990008
RGD:2317212 , RGD:2317211
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Dpyd
dihydropyrimidine dehydrogenase
disease_progression
ISO
RGD
PMID:16619549
RGD:2317631
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Egf
epidermal growth factor
susceptibility
ISO
DNA:SNP: :+61A>G (rs4444903)(human)
RGD
PMID:8093356 PMID:18571008
RGD:2317646 , RGD:2317641
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064
G
Gli1
GLI family zinc finger 1
disease_progression
ISO
DNA:SNP::rs2228226(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Gstm1
glutathione S-transferase mu 1
ISO
RGD
PMID:26925680
RGD:14700928
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
exacerbates
ISO
protein:increased expression:gall bladder (human)
RGD
PMID:26318166
RGD:11528126
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Keap1
Kelch-like ECH-associated protein 1
ISO
DNA:missense mutations, frameshift mutations:cds:multiple (human)
RGD
PMID:18692501
RGD:6893398
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Kras
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:6320174 PMID:11745231 PMID:15696205 PMID:16051643 PMID:17704260 PMID:25741868 PMID:26242988 PMID:28492532 PMID:31666701 PMID:35658005 More...
NCBI chr 4:179,916,255...179,949,613
G
Lrp1b
LDL receptor related protein 1B
ameliorates
ISO
DNA:mutations:multiple: (human)
RGD
PMID:32898339
RGD:150429787
NCBI chr 3:24,594,302...26,715,037
Ensembl chr 3:24,594,991...26,715,505
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:15520168 PMID:15608678 PMID:15930273 PMID:17673550 PMID:21078999 PMID:22658544 PMID:22729223 PMID:22729224 PMID:23946963 PMID:25599672 PMID:25741868 PMID:25880439 PMID:26627007 PMID:26637981 PMID:27631024 PMID:28151489 PMID:28425981 PMID:29661094 PMID:30376034 PMID:30543347 PMID:31536475 PMID:37712948 More...
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
G
Rbp4
retinol binding protein 4
disease_progression
ISO
associated with type 2 diabetes mellitus; protein:decreased expression:blood serum (human)
RGD
PMID:37273108
RGD:329849105
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
G
Rictor
RPTOR independent companion of MTOR, complex 2
ISO
DNA:CNV, amplification:exon (human)
RGD
PMID:24508317
RGD:152995522
NCBI chr 2:55,811,877...55,903,893
Ensembl chr 2:55,811,322...55,901,426
G
Smad4
SMAD family member 4
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:10764709 PMID:16152648 PMID:16436638 PMID:21465659 PMID:22810475 PMID:28492532 More...
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
G
Tp53
tumor protein p53
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:1631137 PMID:1978757 PMID:7478555 PMID:7791795 PMID:8023157 PMID:8062826 PMID:8099841 PMID:8276238 PMID:8425176 PMID:8527048 PMID:8688334 PMID:9150393 PMID:9242456 PMID:9598730 PMID:9825943 PMID:10089074 PMID:11051239 PMID:11370630 PMID:11782540 PMID:11793474 PMID:12406399 PMID:12506399 PMID:12826609 PMID:14673037 PMID:14743206 PMID:15925506 PMID:15993273 PMID:16199547 PMID:16818505 PMID:16861262 PMID:16969106 PMID:17390010 PMID:17417627 PMID:17427234 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17881637 PMID:18978813 PMID:19378321 PMID:19556618 PMID:19711436 PMID:19714490 PMID:20013323 PMID:20128691 PMID:20182602 PMID:20407015 PMID:20436704 PMID:20522432 PMID:21059199 PMID:21305319 PMID:21343334 PMID:21519010 PMID:21601526 PMID:21665182 PMID:21761402 PMID:22186996 PMID:22265402 PMID:22713868 PMID:22915647 PMID:22955915 PMID:23172776 PMID:23246812 PMID:23667202 PMID:23894400 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24382691 PMID:24573247 PMID:24603336 PMID:24651015 PMID:25157968 PMID:25293557 PMID:25544776 PMID:25587027 PMID:25741868 PMID:25925845 PMID:25952993 PMID:26230955 PMID:26425688 PMID:26467025 PMID:26585234 PMID:26619011 PMID:26718964 PMID:26787237 PMID:26911350 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27680515 PMID:27895058 PMID:27959731 PMID:28160093 PMID:28369373 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28861920 PMID:28975465 PMID:29025599 PMID:29752822 PMID:29979965 PMID:30224644 PMID:30322717 PMID:30327374 PMID:30720243 PMID:31105275 PMID:31127191 PMID:31742824 PMID:31775759 PMID:32187361 PMID:32817165 PMID:33300245 PMID:33471991 PMID:34240179 PMID:36988593 More...
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Xrcc1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:polymorphisms: :p.R194W, p.R399Q (human)
RGD
PMID:19266243
RGD:2317128
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:80,141,207...80,168,701
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
ISO
RGD
PMID:7795450
RGD:2317512
NCBI chr 3:10,162,087...10,182,835
Ensembl chr 3:10,162,096...10,191,423
G
Actr3
actin related protein 3
severity
ISO
Squamous Cell/Adenosquamous Carcinoma and Adenocarcinoma;protein:increased expression:gall bladder (human)
RGD
PMID:23320827
RGD:11571623
NCBI chr13:39,353,413...39,396,509
Ensembl chr13:36,800,093...36,844,124
G
Antxr1
ANTXR cell adhesion molecule 1
severity
ISO
RGD
PMID:21545221
RGD:9684943
NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232
G
Birc3
baculoviral IAP repeat-containing 3
exacerbates
ISO
mRNA:increased expression:gall bladder (human)
RGD
PMID:28295868
RGD:153297817
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Cfl1
cofilin 1
severity
ISO
Squamous Cell/Adenosquamous Carcinoma and Adenocarcinoma;protein:increased expression:gall bladder (human)
RGD
PMID:23320827
RGD:11571623
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
G
Clptm1l
CLPTM1-like
susceptibility
ISO
DNA:SNP, haplotype: :rs401681(human)
RGD
PMID:29450669
RGD:150530629
NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
G
Gpx3
glutathione peroxidase 3
severity
ISO
protein:decreased expression:gallbladder (human)
RGD
PMID:24167362
RGD:151665515
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Il10
interleukin 10
susceptibility
ISO
associated with Cholelithiasis
RGD
PMID:19065724
RGD:2317654
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Mir155
microRNA 155
disease_progression
ISO
miRNA:increased expression:gall bladder
RGD
PMID:26885061
RGD:21079444
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mtus1
microtubule associated scaffold protein 1
disease_progression
ISO
RGD
PMID:31882471
RGD:25330344
NCBI chr16:51,202,497...51,347,794
Ensembl chr16:51,253,562...51,347,793
G
Ptch1
patched 1
disease_progression
ISO
RGD
PMID:22407314
RGD:150523794
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
G
Rac1
Rac family small GTPase 1
exacerbates
ISO
protein:increased expression:gallbladder (human)
RGD
PMID:21853342
RGD:155230819
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
G
Tert
telomerase reverse transcriptase
susceptibility
ISO
DNA:SNP, haplotype: :rs2736100(human)
RGD
PMID:29450669
RGD:150530629
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tgfa
transforming growth factor alpha
ISO
RGD
PMID:9542514
RGD:2317470
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Tjp1
tight junction protein 1
ISO
protein:decreased expression:gallbladder
RGD
PMID:19184677
RGD:2325030
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tymp
thymidine phosphorylase
disease_progression
ISO
RGD
PMID:18946757
RGD:2325157
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Ubr5
ubiquitin protein ligase E3 component n-recognin 5
ameliorates
ISO
human cell line in a mouse model
RGD
PMID:30775814
RGD:151665192
NCBI chr 7:69,115,216...69,224,843
Ensembl chr 7:69,116,761...69,224,903
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all